Greater Cannabis Company (GCAN) Cash from Financing Activities (2017 - 2026)
Greater Cannabis Company's (GCAN) quarterly Cash from Financing Activities came in at $5000.0 in Q1 2026, down 98.0% quarter-over-quarter from $250000.0 in Q2 2021.
Greater Cannabis Company (GCAN) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $5000.0 in Q1 2026; TTM through Mar 2026 was $255000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3600.0, changed N/A from the prior year.
- Cash from Financing Activities retreated to $5000.0 in Q1 2026 per GCAN's latest filing, from $250000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $5000.0 in Q1 2026 and bottomed at $5000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -840.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -494.13 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1.48 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -203.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -65.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Jun 30, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Mar 31, 2021 | 250,000.00 |
| Jun 30, 2020 | 13,001.00 |
| Jun 30, 2020 | 13,001.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2020 | 426,667.00 |
| Mar 31, 2019 | 250,000.00 |
| Mar 31, 2019 | 250,000.00 |
| Sep 30, 2018 | 139,217.00 |
| Sep 30, 2018 | 139,217.00 |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 783.00 |
| Mar 31, 2018 | 783.00 |
| Dec 31, 2017 | 5,547.00 |
| Dec 31, 2017 | 5,547.00 |